ACUTE LYMPHOBLASTIC LEUKEMIA WITH FAILED REMISSION
Clinical trials for ACUTE LYMPHOBLASTIC LEUKEMIA WITH FAILED REMISSION explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOBLASTIC LEUKEMIA WITH FAILED REMISSION trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOBLASTIC LEUKEMIA WITH FAILED REMISSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on relapsed leukemia in new trial
Disease control Recruiting nowThis study tests a personalized cell therapy (CAR T-cells) for people with B-cell acute lymphoblastic leukemia that has not responded to standard treatments or has come back. The therapy uses the patient's own immune cells, modified to target and kill cancer cells. The goal is to…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA WITH FAILED REMISSION
Phase: PHASE1, PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 17, 2026 01:30 UTC
-
Can we make cancer-fighting cells at the hospital? new study aims to find out.
Disease control Recruiting nowThis study is testing whether a special type of immune cell therapy (CAR-T cells) can be successfully made right at the hospital for people with B-cell acute lymphoblastic leukemia that has come back or not responded to treatment. The main goal is to see if the manufacturing proc…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA WITH FAILED REMISSION
Phase: NA • Sponsor: King Hussein Cancer Center • Aim: Disease control
Last updated May 17, 2026 01:29 UTC
-
New combo therapy aims to tackle tough blood cancers in kids
Disease control Recruiting nowThis early-phase study tests a drug called venetoclax combined with standard chemotherapy for children, teens, and young adults with aggressive blood cancers like leukemia and myelodysplastic syndrome. The goal is to find the safest dose and understand side effects. About 30 part…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA WITH FAILED REMISSION
Phase: PHASE1 • Sponsor: Andrew E. Place, MD • Aim: Disease control
Last updated May 14, 2026 12:03 UTC